Table 2. Susceptibility of Aeromonas isolates to antimicrobial agents.
| Antimicrobial agent | Number (%) of strains | ||
| (number of strains tested) | susceptible | intermediate resistance | resistant |
| amikacin (11) | 11 (100) | - | - |
| cefotaxime (11) | 11 (100) | - | - |
| ceftazidime (11) | 11 (100) | - | - |
| ceftriaxone (E test) (11) | 11 (100) | - | - |
| ciprofloxacin (11) | 11 (100) | - | - |
| chloramphenicol (11) | 11 (100) | - | - |
| gentamicin (11) | 10 (91) | - | 1 (9) |
| piperacillin–tazobactam (11) | 10 (91) | - | 1 (9) |
| trimethoprim–sulfamethoxazole (11) | 10 (91) | - | 1 (9) |
| imipenem (also meropenem) (11) | 8 (73) | - | 3 (27) |
| cefoxitin (10) | 7 (70) | 2 (20) | 1 (10) |
| nalidixic acid (11) | 7 (64) | - | 4 (36) |
| tetracycline (11) | 6 (55) | - | 5 (45) |
| amoxicillin+clavulanic acid (11) | 3 (27) | 3 (27) | 5 (46) |
| cephalotin (10) | 2 (20) | - | 8 (80) |
Most of the identified strains were resistant to beta-lactam antibiotics but susceptible to third-generation cephalosporin antibiotics.